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ABSTRACT
Synthesis of two series of 1,2- and 1,4-bis(thioureido)benzene derivatives was accomplished by the treatment of corresponding
alkanoyl/aroyl chlorides with potassium thiocyanate in dry acetone to afford the respective isothiocyanates as intermediates.
The latter were treated in situ with 1,2- and 1,4-diaminobenzene, respectively, to afford the title compounds in high yields. A total
of sixteen new compounds are reported herein. The structures of the products were confirmed by spectroscopic techniques (IR,
1H and 13C NMR, mass spectrometry), elemental analysis and in case of 1d, by X-ray diffraction technique. All the synthesized
compounds were also subjected to antibacterial bioevaluation against ten different Gram-positive and Gram-negative bacterial
strains using levofloxacin as the standard drug and were shown to possess promising activities.
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1. Introduction
Thioureas are leading precursors for the synthesis of several
heterocyclic systems, covering the whole field of pharmacy
along with other industrial applications.1,2 Their pharmaceutical
importance was demonstrated from literature as Hedgehog
Inhibiting Activity3 inhibitors of trans-membrane-anchored
carbonic anhydrase,4 and antifungal and antibacterial agents.5
Optically active thioureas and their oxidative cyclization
benzothiazol product derivatives were shown to be antitumor
agents.6 The thiourea-derived drug isoxyl is clinically used
against tuberculosis. Phetsuksiri et. al. have studied the mecha-
nism of action of this drug on Mycobacterium tuberculosis.7 The
catalytic activity of thiourea in the Morita-Baylis-Hillman reac-
tion was also studied8 and further extended to bis(thiourea)
catalysis.9 Tautomeric equilibrium of iminothiol/thiourea deriva-
tives was studied along with their DNA interaction.10
Cyclic voltammetric data of bis(substituted thiourea)ferrocene
derivatives was collected and reported.11 Metal complexes of
bis- and tris-thioureas as non-linear optical material have been
investigated by the Raman spectroscopy.12 Bis-urea and thiourea
containing azo-moieties were shown to exhibit solution phase
anion sensing and binding properties.13 Bis-(aryl)thioureas were
found to be potent and selective inhibitors of te cytomegalovirus
(CMV) in cultured HFF cells.14 Thiourea derivatives were used as
phase change materials for thermal energy storage15 and
1,1’-(naphthalene-1,8-diyl)-3,3’-dibenzoyl-bisthiourea as an
anion-binding receptor.16 In view of the aforementioned
biological and synthetic significance and our previous interest17–9
in various aspects of the chemistry of thioureas, the aim of the
present work was the synthesis of new bis-thiourea deriva-
tives, their conversion into various heterocycles and detailed
bioevaluation.
2. Results and Discussion
Freshly dried acetone was used as a solvent for the preparation
of a clear solution potassium thiocyanate to which dropwise
addition of a suitable alkanoyl/aroyl chloride was carried out.
The corresponding alkanoyl/aroyl isothiocyantes intermediates
thus obtained in situ and were treated with 1,2- or 1,4-diamino-
benzene, respectively, to afford the corresponding series of 1,2-
and 1,4-bis(thioureido)benzenes (Scheme 1). All the synthesized
compounds were purified by recrystallization from aqueous
ethanol and characterized by spectroscopic techniques and in
one case by the X-ray diffraction technique.
Considering compound 1c as a typical 1,2-bis(thioureido)ben-
zene derivative, the structure was supported by FTIR spectros-
copy with appearance of absorption bands at 3251, 3149 cm–1 for
free and associated NH groups along with absorption bands
at 1687 cm–1 for carbonyl carbon and stretching absorption for
the thiocarbonyl carbon at 1255 cm–1. 1H NMR indicated the
presence of two NH as broad singlets at 12.38 and 10.35 ppm
while aromatic protons appeared in range of 7.99–7.33 ppm
while alkyl protons observed in range of 2.56–0.92 ppm.
In the 13C NMR spectrum the thiocarbonyl and carbonyl group
appeared at 180.5 and 174.9 ppm, respectively, the aromatic
carbons at 133.4, 126.8 126.3 ppm and the alkyl carbons at 36.2,
31.0, 24.3, 22.1 and 13.3 ppm. In GCMS the base peak appeared
at 99 a.m.u. due to the benzoyl cation.
The structure of 1d was unequivocally confirmed by single
crystal X-ray analysis (Fig. 1). Single crystals suitable for X-ray
diffraction studies were obtained by slow evaporation of ethanol.
The conformation of the 1d is stabilized by two intramolecular
N-H...O hydrogen bonds. Two methylene chains adopt an
all-trans conformation.
Figure 2 shows the packing diagram with a view of the
bc-plane. The molecules are connected by N-H...S hydrogen
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bonds to zigzag chains running along [1–1 0]. The details of the
structure determination are compiled in Table 1.
Considering compound 1k as a typical 1,4-bis(thioureido)ben-
zene, the appearance of IR stretches at 3258 cm–1 and 3134 cm–1
for free and associated NH groups, at 1693 cm–1 for the carbonyl
group and the thiocarbonyl group at 1251 cm–1 were observed.
1H NMR indicated broad singlets at 12.56 and 11.47 ppm for the
two NH groups while magnetically equivalent aromatic protons
appeared as a single peak at 7.67 ppm and alkyl protons observed
in the range of 2.47–0.87 ppm. In 13C NMR spectrum the
thiocarbonyl carbon appeared at 179.2 ppm and the carbonyl
carbon at 176.0 ppm, while the aromatic carbons were observed
at 135.9 and 124.7 ppm and the alkyl carbons in the range of
36.1–14.2 ppm.
2.1. Antibacterial Activity
Table 2 shows the antibacterial activity data of all synthesized
compounds against ten different bacterial strains. The activity of
the synthesized compounds is presented in zone of inhibition of
bacterial growth in mm (Table 2). The % zone inhibition is based
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Scheme 1
Synthesis of 1,2-and 1,4-bis(N’-substituted thyoureido)benzene derivatives.
Figure 1 Molecular structure with displacement ellipsoids at the 50 % probability level.
on the activity of the reference drug (see the experimental
section for the exact formula). Among all of the tested com-
pounds, 1c showed excellent activity against Bacillus subtilis with
maximum zone of inhibition of 95 % and 76 % against Staphylococ-
cus aureus and Pseudomonas putida. Compound 1g exhibited max-
imum inhibition against Bacillus subtilis of 90 %. Compound 2f
exhibited good activity against a number of bacterial strains with
zones of inhibition: 83 %, 80 %, 73 % and 64 % against Shigella
flexineri, Escherichia coli, Pasteurella multocida and Klebsiella
pneumonae, respectively. Similarly compound 2g showed good
activity against Escherichia coli (80 %), Shigella flexineri (70 %) and
Pasteurella multocida (66 %). Compound 1 was found to be active
against Staphylococcus aureus, Pasteurella multocida and Pseudomonas
aeruginosa with zone inhibition of 84 %, 66 % and 53 %, respec-
tively. 1,4-Bis(N’-substituted thioureido)benzene derivatives
(2a, 2b, 2c and 2e) showed very poor or no zone of inhibition.
The results of antibacterial bioscreening indicate that activities
depend on the length of the hydrocarbon side chain (lipo/
hydrophilicity) in case of aliphatic derivatives and on the elec-
tron-donating or withdrawing nature and position of
substituent in case of the aromatic compounds.
3. Experimental
Melting points of all synthesized compounds were determined
in an open capillary using a digital Gallenkamp (SANYO)
model MPD BM 3.5 apparatus and are uncorrected. 1H NMR and
13C NMR spectra were determined with a 300 MHz Bruker
AM-300 spectrophotometer. FTIR spectra were measured with a
FTS 3000 MX spectrophotometer and mass spectra (EI, 70 eV)
with a GC-MS instrument (Agilent Technologies 1200 series
USA).
3.1. Crystal Structure Determination of 1d




cal absorption correction with the PLATON program20 was
performed. The structure was solved by direct methods and
refined with full-matrix least-squares on F2 using the program
SHELXL97.21 H-atoms bonded to carbon atoms were placed on
ideal positions and refined with fixed isotropic displacement
parameters using a riding model. H-atoms bonded to N were
freely refined.
3.2. General Procedure for Synthesis of Bis(N’-substituted
Thioureido)benzenes
To a solution of KSCN (1.0 mmol) in dry acetone (50 mL) was
dropwise added alkanoyl/aroyl chloride (1.0 mmol) with vigorous
stirring during 30 min. A solution of 1,2-phenylene diamine/
1,4-phenylene diamine (0.5 mmol) in dry acetone (60 mL) was
dropwise added and the reaction mixture was refluxed for 2–4 h
and then poured onto ice-cold water. Filtration of solids
obtained followed by washing with cold water and crystalliza-
tion from ethanol afforded the title compounds. A total of 16
new compounds are reported.
1,2-Bis(N’-butanoylthioureido)benzene (1a)
Yield: 68 %, Rf: 0.67 (Solvent for Rf petroleum ether: Ethyl
acetate, 1:1), m.p. 209–210 °C, IR: 3256 (N-H), 3139 (N-H), 2956
(CH), 1697 (C=O), 1269 (C=S) cm–1. 1H NMR (300 MHz, CDCl3):
d 12.26 (s, 2H, CO-NH-CS), 11.51 (s, 2H, CS-NH-C), 7.84–7.81 (m,
2H, ArH), 7.35–7.32 (m, 2H, ArH), 2.42 (t, 4H, J = 7.1 Hz, 2CH2),
1.60–1.53 (m, 4H, 2CH2), 0.91–0.87 (t, 6H, J = 6.9 Hz, 2CH3),
13C NMR (75 MHz, CDCl3): d 180.6, 175.5, 133.6, 127.4, 127.0, 37.9,
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Figure 2 Packing diagram with view onto the bc-plane. Hydrogen bonds are drawn as dashed lines.
18.2, 13.8. EIMS m/z (%): 366 [M+] (14), 71 (100 %), 87 (50). Anal.
calcd. for C16H22N4O2S2: C, 52.43, H, 6.05, N, 15.29, S, 17.50 %,
found: C, 52.31, H, 6.19, N, 15.41, S, 17.62 %.
1,2-Bis(N’-pentanoyl thioureido)benzene (1b)
Yield: 72 %, Rf: 0.74 (Solvent for Rf petroleum ether: Ethyl
acetate, 1:1), m.p. 178–180 °C, IR: 3244 (N-H), 3140 (N-H), 2958
(CH), 1690 (C=O), 1257 (C=S) cm–1. 1H NMR (300 MHz, CDCl3):
d 12.02 (s, 2H, CO-NH-CS), 11.49 (s, 2H, CS-NH-C), 7.85–7.51 (m,
2H, ArH), 7.32–7.16 (m, 2H, ArH), 2.42 (t, 4H, J = 7.0 Hz, 2CH2),
1.66–1.42 (m, 8H, 4CH2), 0.92–0.87 (t, 6H, J = 6.9 Hz, 2CH3),
13C NMR (75 MHz, CDCl3): d 180.5, 175.6, 130.6, 128.3, 126.1, 37.4,
18.2, 15.6, 13.8. EIMS m/z (%): 394 [M+] (17), 85 (100 %), 101 (49).
Anal. calcd. for C18H26N4O2S2: C, 54.79, H, 6.64, N, 14.20, S,
16.25 %. found: C, 54.12, H, 6.87, N, 14.42, S, 16.10 %.
1,2-Bis(N’-hexanoyl thioureido)benzene (1c)
Yield: 64 %, Rf: 0.76 (Solvent for Rf petroleum ether: Ethyl
acetate, 1:1), m.p. 138–140 °C, IR: 3251 (N-H), 3149 (N-H), 2955
(CH), 1687 (C=O), 1255 (C=S) cm–1. 1H NMR (300 MHz, CDCl3):
d 12.38 (s, 2H, CO-NH-CS), 10.35 (s, 2H, CS-NH-C), 7.99–7.96 (m,
2H, ArH), 7.37–7.33 (m, 2H, ArH), 2.56 (t, 4H, J = 7.2, 2CH2), 1.75–
1.65 (m, 4H, 2CH2), 1.42–1.34 (m, 8H, 4CH2), 0.92 (t, J = 6.8, 6H,
2CH3),
13C NMR (75 MHz, CDCl3): d 180.5, 174.9, 133.4, 126.8,
126.3, 36.2, 31.0, 24.38, 22.1, 13.3. EIMS m/z (%): 422 [M+] (16), 99
(100 %), 115 (32). Anal. Calcd. for C20H30N4O2S2: C, 56.84, H, 7.16,
N, 13.26, S, 15.17 %. found: C, 56.42, H, 7.01, N, 13.47, S, 15.32 %.
1,2-Bis(N’-octanoyl thioureido)benzene (1d)
Yield: 61 %, Rf: 0.79 (Solvent for Rf petroleum ether: Ethyl
acetate, 1:1), m.p. 137–138 °C, IR: 3268 (N-H), 3167 (N-H), 2959
(CH), 1695 (C=O), 1262 (C=S) cm–1. 1H NMR (300 MHz, CDCl3):
d 12.26 (s, 2H, CO-NH-CS), 11.50 (s, 2H, CS-NH-C), 7.86–7.83 (m,
2H, ArH), 7.36–7.31 (m, 2H, ArH), 2.51 (t, 4H, J = 7.5 Hz, 2CH2),
1.56–1.51 (m, 4H, 2CH2), 1.39–1.20 (m, 16H, 8CH2), 0.86 (t,
J = 6.5 Hz, 6H, 2CH3),
13C NMR (75 MHz, CDCl3): d 180.6, 175.6,
133.5, 127.3, 126.9, 36.1, 31.3, 30.1, 28.9, 24.8, 22.5, 14.4. EIMS m/z
(%): 478 [M+] (10), 127 (100 %), 143 (35). Anal. Calcd. for
C24H38N4O2S2: C, 60.21, H, 8.00, N, 11.70, S, 13.40 %. found: C,
60.31, H, 8.36, N, 11.88, S, 13.66 %.
1,2-Bis(N’-benzoyl thioureido)benzene (1e)
Yield: 69 %, Rf: 0.68 (Solvent for Rf petroleum ether: Ethyl
acetate, 1:1), m.p. 156–158 °C, IR: 3234 (N-H), 3142 (N-H), 1672
(C=O), 1244 (C=S) cm–1. 1H NMR (300 MHz, CDCl3): d 12.63 (s,
2H, CO-NH-CS), 10.48 (s, 2H, CS-NH-C), 8.06–8.00 (m, 6H, ArH),
7.70–7.65 (m, 2H, ArH), 7.56–7.51 (m, 4H, ArH), 7.44–7.41 (m, 2H,
ArH),13C NMR (75 MHz, CDCl3): d 180.5, 167.9, 133.6, 133.3, 132.2,
128.6, 128.3, 127.2, 126.5. EIMS m/z (%): 434 [M+] (15), 105 (100 %),
121 (40). Anal. Calcd. for C22H18N4O2S2: C, 60.81, H, 4.18, N, 12.89,
S, 14.76 %. found: C, 60.45, H, 4.26, N, 12.77, S, 14.69 %.
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Table 1 Crystal data and structure refinement for 1d.





Space group P -1
Unit cell dimensions a = 5.2123(4) Å a = 85.665(6) °
b = 14.5145(12) Å b = 88.703(6) °
c = 17.1538(13) Å g = 86.550(6) °
Volume 1291.48(18) Å3
Density (calculated) 1.231 mg m–3
Absorption coefficient 0.233 mm–1
F(000) 516
Crystal size 0.28 × 0.23 × 0.11 mm3
Theta range for data collection 3.55 to 25.58 °
Index ranges –6£h£6, –17£k£14, –20£l£20
Reflections collected 13407
Independent reflections 4803 [R(int) = 0.0547]
Completeness to theta = 25.00 ° 99.4 %
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.9748 and 0.9375
Refinement method Full-matrix least-squares on F2
Data/restraints/parameters 4803/0/306
Goodness-of-fit on F2 1.067
Final R indices [I>2sigma(I)] R1 = 0.0381, wR2 = 0.0999
R indices (all data) R1 = 0.0462, wR2 = 0.1030
Extinction coefficient 0.013(2)
Largest diff. peak and hole 0.251 and –0.195 e.Å–3
CCDC No. CCDC 782145
Table 2 Antibacterial activity of compounds (1a–h, 2a–h).
Compound P.m. B.s. E.c. S.a. P. p. P. a. S. t. M.l. S. f. K.p.
1a 10 12 – 13 16 – – 16 17 –
1b 18 – 11 17 21 13 08 15 19 07
1c 21 19 15 19 23 15 – 17 11 –
1d 08 – – 04 11 13 – – 17 11
1e 13 07 – 15 – 06 – 16 21 15
1f 10 05 – 11 – 14 05 – – –
1g 15 18 06 18 10 – – 09 19 –
1h 20 11 16 21 13 15 – 06 – –
2a – 05 – – 06 11 – – – –
2b 10 – 05 – – – – 07 10 –
2c – 07 – 05 – 06 – – – 07
2d 05 – 07 – – 04 – – – –
2e 18 – 20 11 06 – – 05 21 –
2f 22 12 24 15 10 15 18 15 25 16
2g 20 10 24 11 08 12 15 13 21 14
2h 07 – 05 – 06 – 10 – 08 –
Levofloxacin 30 20 30 25 30 28 30 25 30 25
Activity is presented in millimetres (mm),
(–) = No activity measured
1,2-Bis(N’-(2-chlorobenzoyl) thioureido)benzene (1f)
Yield: 72 %, Rf: 0.58 (Solvent for Rf petroleum ether: Ethyl
acetate, 1:1), m.p. 200–202 °C, IR: 3250 (N-H), 3142 (N-H), 1670
(C=O), 1240 (C=S) cm–1. 1H NMR (300 MHz, CDCl3): d 12.22 (s,
2H, CO-NH-CS), 12.14 (s, 2H, CS-NH-C), 7.95–7.92 (m, 2H, ArH),
7.56–7.49 (m, 6H, ArH), 7.42–7.37 (m, 4H, ArH), 13C NMR
(75 MHz, CDCl3): d 180.4, 168.1, 134.7, 133.7, 132.6, 130.5, 130.0,
129.6, 127.6, 127.4, 127.1. EIMS m/z (%): 503 [M+] (10), 138 (100 %),
155 (27). Anal. Calcd. for C22H16Cl2N4O2S2: C, 52.49, H, 3.20, N,
11.13, S, 12.74 %. found: C, 52.20, H, 3.11,  N, 11.09, S, 12.88 %.
1,2-Bis(N’-(4-chlorobenzoyl)thioureido)benzene (1g)
Yield: 66 %, Rf: 0.71 (Solvent for Rf petroleum ether: Ethyl
acetate, 1:1), m.p. 210–212 °C, IR: 3230 (N-H), 3152 (N-H), 1670
(C=O), 1251 (C=S) cm–1. 1H NMR (300 MHz, CDCl3): d 12.32 (s,
2H, CO-NH-CS), 12.11 (s, 2H, CS-NH-C), 7.87–7.80 (m, 2H, ArH),
7.62–7.54 (m, 6H, ArH), 7.42–7.36 (m, 4H, ArH), 13C NMR
(75 MHz, CDCl3): d 178.5, 168.1, 134.8, 133.7, 131.5, 130.9, 130.2,
128.6, 127.1. EIMS m/z (%): 503 [M+] (11), 138 (100 %), 155 (29).
Anal. Calcd. for C22H16Cl2N4O2S2: C, 52.49, H, 3.20, N, 11.13, S,
12.74 %. found: C, 52.67, H, 3.29, N, 11.25, S, 12.45 %.
1,2-Bis(N’-(4-nitrobenzoyl)thioureido)benzene (1h)
Yield: 58 %, Rf: 0.54 (Solvent for Rf petroleum ether: Ethyl
acetate, 1:1), m.p. 179–181 °C, IR: 3260 (N-H), 3148 (N-H), 1669
(C=O), 1254 (C=S) cm–1. 1H NMR (300 MHz, CDCl3): d 12.30 (s,
2H, CO-NH-CS), 11.24 (s, 2H, CS-NH-C), 7.94–7.83 (m, 4H, ArH),
7.55–7.49 (m, 4H, ArH), 7.37–7.31 (m, 4H, ArH), 13C NMR
(75 MHz, CDCl3): d 180.6, 168.3, 139.7, 138.8, 133.9, 130.5, 129.7,
124.6, 123.4. EIMS m/z (%): 524 [M+] (11), 150 (100 %), 166 (24).
Anal. Calcd. for C22H16N6O6S2: C, 50.38, H, 3.07, N, 16.02, S,
12.23 %. found: C, 50.48, H, 3.19, N, 16.29, S, 12.34 %.
1,4-Bis(N’-butanoyl thioureido)benzene (2a)
Yield: 75 %, Rf: 0.52 (Solvent for Rf petroleum ether: Ethyl
acetate, 1:1), m.p. 180–181 °C, IR: 3261 (N-H), 3151 (N-H), 2959
(CH), 1691 (C=O), 1250 (C=S) cm–1. 1H NMR (300 MHz, CDCl3):
d 12.39 (s, 2H, CO-NH-CS), 11.01 (s, 2H, CS-NH-C), 7.59 (s, 4H,
ArH), 2.36 (t, 4H, J = 6.99 Hz, 2CH2), 1.52–1.50 (m, 4H, 2CH2),
0.90–0.79 (t, 6H, J = 6.9 Hz, 2CH3),
13C NMR (75 MHz, CDCl3):
d 179.8, 176.6, 134.4, 124.4, 38.6, 18.8, 13.1. EIMS m/z (%): 366 [M+]
(15), 71 (100 %), 87 (55). Anal. calcd. for C16H22N4O2S2: C, 52.43, H,
6.05, N, 15.29, S, 17.50 %. found: C, 52.29, H, 6.21, N, 15.01, S,
17.41 %.
1,4-Bis(N’-pentanoyl thioureido)benzene (2b)
Yield: 71 %, Rf: 0.77 (Solvent for Rf petroleum ether: Ethyl
acetate, 1:1), m.p. 215–217 °C, IR: 3254 (N-H), 3164 (N-H), 2953
(CH), 1677 (C=O), 1261 (C=S) cm–1. 1H NMR (300 MHz, CDCl3):
d 11.98 (s, 2H, CO-NH-CS), 11.36 (s, 2H, CS-NH-C), 7.92 (s, 4H,
ArH), 2.56 (t, 4H, J = 7.0 Hz, 2CH2), 1.74–1.39 (m, 8H, 4CH2),
0.93–0.87 (t, 6H, J = 6.9 Hz, 2CH3),
13C NMR (75 MHz, CDCl3): d
180.4, 175.4, 134.6, 123.1, 37.5, 18.4, 15.9, 12.2. EIMS m/z (%): 394
[M+] (20), 85 (100 %), 101 (41). Anal. calcd. for C18H26N4O2S2: C,
54.79, H, 6.64, N, 14.20, S, 16.25 %. found: C, 54.42, H, 6.96, N,
14.31, S, 16.36 %.
1,4-Bis(N’-hexanoyl thioureido)benzene (2c)
Yield: 74 %, Rf: 0.79 (Solvent for Rf petroleum ether: Ethyl
acetate, 1:1), m.p. 168–169 °C, IR: 3258 (N-H), 3134 (N-H), 2938
(CH), 1693 (C=O), 1251 (C=S) cm–1. 1H NMR (300 MHz, CDCl3):
d 12.56 (s, 2H, CO-NH-CS), 11.47 (s, 2H, CS-NH-C), 7.67 (s, 4H,
ArH), 2.47 (t, 4H, J = 7.5, 2CH2), 1.59–1.54 (m, 4H, 2CH2),
1.29–1.27 (m, 8H, 4CH2), 0.87 (t, 6H, J = 6.3, 2CH3),
13C NMR
(75 MHz, CDCl3): d 179.2, 176.0, 135.9, 124.7, 36.1, 31.1, 24.4, 22.3,
14.2. EIMS m/z (%): 422 [M+] (15), 99 (100 %), 115 (35). Anal.
Calcd. for C20H30N4O2S2: C, 56.84, H, 7.16, N, 13.26, S, 15.17 %.
found: C, 56.57, H, 7.09, N, 13.11, S, 15.14 %.
1,4-Bis(N’-octanoyl thioureido)benzene (2d)
Yield: 69 %, Rf: 0.80 (Solvent for Rf petroleum ether: Ethyl
acetate, 1:1), m.p. 170–172 °C, IR: 3242 (N-H), 3155 (N-H), 2959
(CH), 1686 (C=O), 1261 (C=S) cm–1. 1H NMR (300 MHz, CDCl3):
d 12.56 (s, 2H, CO-NH-CS), 11.46 (s, 2H, CS-NH-C), 7.66 (s, 4H,
ArH), 2.45 (t, 4H, J = 7.5, 2CH2), 1.58–1.53 (m, 4H, 2CH2),
1.31–1.25 (m, 16H, 8CH2), 0.86 (t, J = 6.4, 6H, 2CH3),
13C NMR
(75 MHz, CDCl3): d 179.1, 176.0, 135.9, 124.7, 36.2, 31.5, 28.8, 24.7,
22.5, 21.1, 14.4. EIMS m/z (%): 478 [M+] (11), 127 (100 %), 143 (37).
Anal. Calcd. for C24H38N4O2S2: C, 60.21, H, 8.00, N, 11.70, S,
13.40 %. found: C, 60.33, H, 8.24, N, 11.69, S, 13.12 %.
1,4-Bis(N’-benzoyl thioureido)benzene (2e)
Yield: 70 %, Rf: 0.57 (Solvent for Rf petroleum ether: Ethyl
acetate, 1:1), m.p. 223–225 °C, IR: 3235 (N-H), 3167 (N-H), 1655
(C=O), 1261 (C=S) cm–1. 1H NMR (300 MHz, CDCl3): d 12.59 (s,
2H, CO-NH-CS), 10.88 (s, 2H, CS-NH-C), 7.99–7.78 (m, 6H, ArH),
7.67 (s, 4H, ArH), 7.38–7.21 (m, 4H, ArH), 13C NMR (75 MHz,
CDCl3): d 178.3, 166.1, 134.5, 131.2, 129.8, 127.2, 125.6, 123.7. EIMS
m/z (%): 434 [M+] (14), 105 (100 %), 121 (46). Anal. Calcd. for
C22H18N4O2S2: C, 60.81, H, 4.18, N, 12.89, S, 14.76 %. found: C,
60.69, H, 4.37, N, 12.50, S, 14.91 %.
1,4-Bis(N’-(2-chloro benzoyl) thioureido)benzene (2f)
Yield: 64 %, Rf: 0.69 (Solvent for Rf petroleum ether: Ethyl
acetate, 1:1), m.p. 175–177 °C, IR: 3230 (N-H), 3136 (N-H), 1667
(C=O), 1257 (C=S) cm–1. 1H NMR (300 MHz, CDCl3): d 12.22 (s,
2H, CO-NH-CS), 12.14 (s, 2H, CS-NH-C), 7.84–7.79 (m, 2H, ArH),
7.74 (m, 4H, ArH), 7.67 (s, 4H, ArH), 7.33–7.28 (m, 2H, ArH),
13C NMR (75 MHz, CDCl3): d 181.6, 166.4, 134.5, 133.4, 131.8, 130.2,
128.6, 126.6, 125.9, 124.0. EIMS m/z (%): 503 [M+] (14), 138 (100 %),
155 (20). Anal. Calcd. for C22H16Cl2N4O2S2: C, 52.49, H, 3.20, N,
11.13, S, 12.74 %. found: C, 52.25, H, 3.40, N, 11.21, S, 12.91 %.
1,4-Bis(N’-(4-chloro benzoyl) thioureido)benzene (2g)
Yield: 67 %, Rf: 0.71 (Solvent for Rf petroleum ether: Ethyl
acetate, 1:1), m.p. 230–232 °C, IR: 3257 (N-H), 3142 (N-H), 1665
(C=O), 1249 (C=S) cm–1. 1H NMR (300 MHz, CDCl3): d 12.02 (s,
2H, CO-NH-CS), 11.31 (s, 2H, CS-NH-C), 7.84 (d, 4H, J = 7.5 Hz,
ArH), 7.61 (s, 4H, ArH), 7.50 (d, 4H, J=7.5 Hz, ArH), 13C NMR
(75 MHz, CDCl3): d 179.6, 168.1, 133.7, 131.7, 130.5, 132.9, 127.0,
124.1. EIMS m/z (%): 503 [M+] (13), 138 (100 %), 155 (21). Anal.
Calcd. for C22H16Cl2N4O2S2: C, 52.49, H, 3.20, N, 11.13, S, 12.74 %.
found: C, 52.39, H, 3.07, N, 11.00, S, 12.51 %.
1,4-Bis(N’-(4-nitro benzoyl) thioureido)benzene (2h)
Yield: 61 %, Rf: 0.68 (Solvent for Rf petroleum ether: Ethyl
acetate, 1:1), m.p. 234–236 °C, IR: 3242 (N-H), 3149 (N-H), 1658
(C = O), 1241 (C=S) cm–1. 1H NMR (300 MHz, CDCl3): d 12.25 (s,
2H, CO-NH-CS), 11.45 (s, 2H, CS-NH-C), 7.94 (d, 4H, J = 7.6 Hz,
ArH), 7.65 (s, 4H, ArH), 7.56 (d, 4H, J = 7.5 Hz, ArH), 13C NMR
(75 MHz, CDCl3): d 179.9, 166.4, 139.8, 138.0, 133.5, 131.5, 128.9,
124.6. EIMS m/z (%): 524 [M+] (14), 150 (100 %), 166 (17) Anal.
Calcd. for C22H16N6O6S2: C, 50.38, H, 3.07, N, 16.02, S, 12.23 %.
found: C, 50.59, H, 3.21, N, 16.21, S, 12.12 %.
3.3. Pharmacological Assays
In vitro evaluation of antibacterial activity of the compounds
was carried out by agar well diffusion assay20 against ten differ-
ent Gram-positive and Gram-negative bacteria (Pasteurella
multocida (P.m.), Bacillus subtilis (B.s.), Escherichia coli (E.c.), Staph-
ylococcus aureus (S.a.), Pseudomonas putida (P.p.), Pseudomonas
aeruginosa (P.a.), Salmonella typhi (S.t.), Micrococcus luteus (M.l.),
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Shigella flexineri (S.f.) and Klebsiella pneumonae (K.p.)). Antibacte-
rial activity was determined by using the Mueller Hinton Agar
(MHA).n The fresh inoculums of these bacteria were prepared
and diluted by sterilized normal saline. The turbidity of these
cultures was adjusted by using 0.5 Mc-Farland. A homogeneous
bacterial lawn was developed by sterile cotton swabs. The inocu-
lated plates were bored by 6 mm sized borer to make the wells.
The sample dilutions were prepared by dissolving each sample
(1.0 mg) in 1.0 mL of DMSO used as negative control in this
bioassay. The equimolar concentration of Levofloxacin (1.0 mg
mL–1), a broad spectrum antibiotic (positive control) was pre-
pared. These plates were incubated at 37 °C for 24 hours. Anti-
bacterial activity of the compounds was determined by measur-
ing the diameter of zone of inhibition (mm, ± standard devia-
tion) and presented by subtracting the activity of the negative
control in Table 2. The % zone inhibition is therefore defined as:
% zone inhibition =
zone of inhibition by compound
zone of inhibition by standard drug
× 100 .
4. Conclusion
Two novel series of 1,2- and 1,4-bis(N’-substituted thioureido)
benzenes (a total of 16 new compounds) were synthesized by
treatment with 1,2- and 1,4-diaminobenzene with respective
isothiocyanates produced in situ. The X-ray single crystal diffrac-
tion analysis of compound 1d shows that the conformation is
stabilized by two intramolecular N-H...O hydrogen bonds and
the two methylene chains adopt an all-trans conformation. The
results of antibacterial screening indicated that compound 1c
from 1,2-bis(N’-substituted thioureido)benzene series showed
excellent activity against Bacillus subtilis, Staphylococcus aureus
and Pseudomonas putida, respectively. Whereas amongst
1,4-bis(N’-substituted thioureido)benzene series, compound 2f
exhibited good activity against Shigella flexineri, Escherichia coli,
Pasteurella multocida and Klebsiella pneumonae compared with
levofloxacin, the standard drug.
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